Anne Schnatterly serves as director of the Clinical Research Unit at the WVU Cancer Institute, as well as the executive director of West Virginia Cancer Clinical Trials Network (WVCTN), which represents six research locations across the state of West Virginia.
Schnatterly joined WVU with the challenge of developing WVU Medicine’s cancer portfolio and bringing the newly-created West Virginia Cancer Clinical Trials Network from concept to reality. She has enjoyed the collaboration and reciprocal growth with the cancer team in the state.
She began her career in cancer research at University Hospitals of Cleveland Seidman Cancer Center, concentrating in lung cancer and HIV malignancies, including the opportunity to work with international sites in Africa. She progressed into a management track and oversaw clinical and financial operations, including a regional network and Phase I developmental therapeutics program.
Hannah Hazard-Jenkins, MD
Director, WVU Cancer Institute; Director and Associate Chair of Surgery for Cancer Services, WVU Cancer Institute
Nathan Burt, MHA
Interim Vice President, WVU Cancer Institute; Vice President of Operations, J.W. Ruby Memorial Hospital
Deborah Falconi, MSN, RN, OCN
Assistant Vice President, Cancer Services Operation and Strategy, WVU Cancer Institute
Michael Ridinger, MBA, RN, BSN
Associate Director, WVU Cancer Institute; Administrator, WVU Section of Hematology/Oncology